← Leaderboards
Amy Jo Wagers
Joslin Diabetes Center
$26,399,310
Attributed
$27,481,093
Total exposure
19
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,481,093 · 19
By mechanism
R01$12,365,894 · 7
DP1$5,915,000 · 1
P30$4,019,118 · 5
DP2$2,424,125 · 1
U01$1,395,548 · 1
R24$816,608 · 1
Top collaborators
- Thomas F Serwold2 shared
- George L King1 shared
- Andrzej S Krolewski1 shared
Most similar at Joslin Diabetes Center
Same institution · by research overlap
- Alessandro Doria$38,225,772
- Mary E Patti$12,250,300
- Stephan Kissler$1,775,593
- George L King$33,057,965
- Andrzej S Krolewski$27,069,493
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBaseIn VivoGeneticPathway InteractionsProteinsBloodProductionTissuesOrganStem CellsAnimalsFunctional DisorderMuscleCell TypeMediatingLifePhenotypeTechnologyGenesAgingRepairedResponseRegenerative
Grant awards (65)
Disrupted Communication Between Blood Cells and Non-blood Organs as a Mediator of Aging Pathologies$694,740
U01 · FY2025 · AG · contact PI
Modulating the adaptive immune response to enhance the efficiency of in vivo gene editing in muscle$537,378
R01 · FY2025 · NS
Flow Cytometry Core$284,345
P30 · FY2025 · DK · contact PI
Disrupted Communication Between Blood Cells and Non-blood Organs as a Mediator of Aging Pathologies$700,808
U01 · FY2024 · AG · contact PI
Modulating the adaptive immune response to enhance the efficiency of in vivo gene editing in muscle$537,378
R01 · FY2024 · NS
Flow Cytometry Core$284,346
P30 · FY2024 · DK · contact PI
Flow Cytometry Core$243,368
P30 · FY2023 · DK · contact PI
Uncovering molecular effectors of mammalian aging$1,183,000
DP1 · FY2022 · AG · contact PI
Flow Cytometry Core$242,656
P30 · FY2022 · DK · contact PI
Uncovering molecular effectors of mammalian aging$1,183,000
DP1 · FY2021 · AG · contact PI
In vivo gene editing of hematopoietic stem and progenitor cells$417,500
R01 · FY2021 · HL · contact PI
Uncovering molecular effectors of mammalian aging$1,183,000
DP1 · FY2020 · AG · contact PI
Regulation and function of Growth Differentiation Factor 11 during development and aging$527,746
R01 · FY2020 · AG · contact PI
Investigating GDF11 and MSTN as candidate circulating geronic factors$503,172
R01 · FY2020 · AG · contact PI
In vivo gene editing of hematopoietic stem and progenitor cells$417,500
R01 · FY2020 · HL · contact PI
Uncovering molecular effectors of mammalian aging$1,183,000
DP1 · FY2019 · AG · contact PI
Regulation and function of Growth Differentiation Factor 11 during development and aging$527,746
R01 · FY2019 · AG · contact PI
Investigating GDF11 and MSTN as candidate circulating geronic factors$503,172
R01 · FY2019 · AG · contact PI
In vivo gene editing of hematopoietic stem and progenitor cells$416,975
R01 · FY2019 · HL · contact PI
Genome Editing Core$232,352
P30 · FY2019 · DK · contact PI
2019 Stem Cells and Cancer Gordon Research Conference(GRC)and Gordon Research Seminar(GRS)$4,000
R13 · FY2019 · CA · contact PI
Uncovering molecular effectors of mammalian aging$1,183,000
DP1 · FY2018 · AG · contact PI
Regulation and function of Growth Differentiation Factor 11 during development and aging$527,746
R01 · FY2018 · AG · contact PI
Investigating GDF11 and MSTN as candidate circulating geronic factors$517,706
R01 · FY2018 · AG · contact PI
In vivo gene editing of hematopoietic stem and progenitor cells$432,401
R01 · FY2018 · HL · contact PI
Genome Editing Core$236,912
P30 · FY2018 · DK · contact PI
Regulation and function of Growth Differentiation Factor 11 during development and aging$527,746
R01 · FY2017 · AG · contact PI
Investigating GDF11 and MSTN as candidate circulating geronic factors$511,791
R01 · FY2017 · AG · contact PI
Genome Editing Core$240,537
P30 · FY2017 · DK · contact PI
Regulation and Function of Growth Differentiation Factor 11 During Development and Aging$115,838
R01 · FY2017 · AG · contact PI
Regulation and function of Growth Differentiation Factor 11 during development and aging$538,067
R01 · FY2016 · AG · contact PI
GDF11: an age-variant hormonal regulator of tissue homeostasis and repair$202,800
R56 · FY2016 · AG · contact PI
Core E: Induced Pluripotent Stem Cells Core$182,280
P30 · FY2016 · DK · contact PI
Regulation and function of Growth Differentiation Factor 11 during development and aging$338,000
R56 · FY2015 · AG · contact PI
Epigenomic drivers of human muscle progenitor cells in development and disease$318,000
R01 · FY2015 · ES · contact PI
Core E: Induced Pluripotent Stem Cells Core$173,033
P30 · FY2015 · DK · contact PI
Epigenomic drivers of human muscle progenitor cells in development and disease$338,000
R01 · FY2014 · ES · contact PI
Reversing age-related dysfunction of skeletal muscle stem cells$327,728
R01 · FY2014 · AG · contact PI
Core E: Induced Pluripotent Stem Cells Core$182,281
P30 · FY2014 · DK · contact PI
Control of HSC proliferation and migration by the transcription factor EGR1$380,526
R01 · FY2013 · HL · contact PI
Reversing age-related dysfunction of skeletal muscle stem cells$309,703
R01 · FY2013 · AG · contact PI
Core E: Induced Pluripotent Stem Cells Core$172,015
P30 · FY2013 · DK · contact PI
Control of HSC proliferation and migration by the transcription factor EGR1$399,713
R01 · FY2012 · HL · contact PI
Reversing age-related dysfunction of skeletal muscle stem cells$327,728
R01 · FY2012 · AG · contact PI
Core E: Induced Pluripotent Stem Cells Core$183,531
P30 · FY2012 · DK · contact PI
JOSLIN--WAGERS$58,693
P30 · FY2012 · AG · contact PI
Control of HSC proliferation and migration by the transcription factor EGR1$403,750
R01 · FY2011 · HL · contact PI
Reversing age-related dysfunction of skeletal muscle stem cells$327,728
R01 · FY2011 · AG · contact PI
FLOW CYTOMETRY CORE$207,684
P30 · FY2011 · DK · contact PI
JOSLIN--WAGERS$63,613
P30 · FY2011 · AG · contact PI
Protective Factors Against the Development of Microvascular Complications$816,608
R24 · FY2010 · DK
Control of HSC proliferation and migration by the transcription factor EGR1$403,750
R01 · FY2010 · HL · contact PI
Reversing age-related dysfunction of skeletal muscle stem cells$340,956
R01 · FY2010 · AG · contact PI
FLOW CYTOMETRY CORE$234,958
P30 · FY2010 · DK · contact PI
JOSLIN--WAGERS$68,381
P30 · FY2010 · AG · contact PI
Control of HSC proliferation and migration by the transcription factor EGR1$398,600
R01 · FY2009 · HL · contact PI
Reversing age-related dysfunction of skeletal muscle stem cells$324,742
R01 · FY2009 · AG · contact PI
FLOW CYTOMETRY CORE$214,599
P30 · FY2009 · DK · contact PI
Control of HSC proliferation and migration by the transcription factor EGR1$198,604
R01 · FY2009 · HL · contact PI
JOSLIN--WAGERS$71,496
P30 · FY2009 · AG · contact PI
Reversing age-related dysfunction of skeletal muscle stem cells$6,504
R01 · FY2009 · AG · contact PI
Aging and Rejuvenation of the hematopoietic stem cell niche$2,424,125
DP2 · FY2008 · OD · contact PI
FLOW CYTOMETRY CORE$209,099
P30 · FY2008 · DK · contact PI
JOSLIN--WAGERS$56,049
P30 · FY2008 · AG · contact PI
FLOW CYTOMETRY CORE$176,890
P30 · FY2007 · DK · contact PI